A mutation in the human uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia

Blood

Volumn 119, Issue 6, 2012, Pages 1399-1406

  Gorska, Magdalena M ^a,b   Alam, Rafeul ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE LCK; RAB11 PROTEIN;

ADULT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL PNEUMONIA; BRONCHIOLITIS OBLITERANS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELL PROLIFERATION; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DERMATITIS; DISEASE ASSOCIATION; ENDOSOME; ENZYME ACTIVATION; ENZYME LOCALIZATION; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION; GENE INTERACTION; GENE SEQUENCE; GENETIC TRANSDUCTION; HERPES ZOSTER; HERPETIC STOMATITIS; HUMAN; HUMAN CELL; IDIOPATHIC CD4 LYMPHOPENIA; LYMPHOCYTOPENIA; MISSENSE MUTATION; NAIL INFECTION; NUCLEOTIDE SEQUENCE; OTITIS MEDIA; PATHOGENESIS; PRIORITY JOURNAL; SINUSITIS; UNCOORDINATED 119 GENE;

EID: 84856911463     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-350686     Document Type: Article

References (33)

1. Smith DK, Neal JJ, Holmberg SD. Unexplained opportunistic infections and CD4+T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med. 1993;328(6):373-379. (Pubitemid 23042284)
2. Lin SJ, Chao HC, Yan DC, Kuo ML. Idiopathic CD4+ T lymphocytopenia in two siblings. Pediatr Hematol Oncol. 2001;18(2):153-156.
3. Freier S, Kerem E, Dranitzki Z, et al. Hereditary CD4+ T lymphocytopenia. Arch Dis Child. 1998;78(4):371-372. (Pubitemid 28180562)
4. Isgrò A, Sirianni MC, Gramiccioni C, Mezzaroma I, Fantauzzi A, Aiuti F. Idiopathic CD4+ lymphocytopenia may be due to decreased bone marrow clonogenic capability. Int Arch Allergy Immunol. 2005;136(4):379-384.
5. Laurence J, Mitra D, Steiner M, Lynch DH, Siegal FP, Staiano-Coico L. Apoptotic depletion of CD4+ T cells in idiopathic CD4+ T lymphocytopenia. J Clin Invest. 1996;97(3):672-680. (Pubitemid 26057085)
6. Scott-Algara D, Balabanian K, Chakrabarti LA, et al. Idiopathic CD4+ T-cell lymphocytopenia is associated with impaired membrane expression of the chemokine receptor CXCR4. Blood. 2010;115(18):3708-3717.
7. Li FY, Chaigne-Delalande B, Kanellopoulou C, et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature. 2011;475(7357):471-476.
8. Kuijpers TW, Ijspeert H, van Leeuwen EM, et al. Idiopathic CD4+ T lymphopenia without autoimmunity or granulomatous disease in the slipstream of RAG mutations. Blood. 2011;117(22):5892-5896.
9. Straus DB, Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 1992;70(4):585-593.
10. Molina TJ, Kishihara K, Siderovski DP, et al. Profound block in thymocyte development in mice lacking p56lck. Nature. 1992;357(6374):161-164.
11. Lovatt M, Filby A, Parravicini V, Werlen G, Palmer E, Zamoyska R. Lck regulates the threshold of activation in primary T cells, while both Lck and Fyn contribute to the magnitude of the extracellular signal-related kinase response. Mol Cell Biol. 2006;26(22):8655-8665. (Pubitemid 44748595)
12. Salmond RJ, Filby A, Qureshi I, Caserta S, Zamoyska R. T-cell receptor proximal signaling via the Src-family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance. Immunol Rev. 2009;228(1):9-22.
13. Gorska MM, Stafford SJ, Cen O, Sur S, Alam R. Unc119, a novel activator of Lck/Fyn, is essential for T cell activation. J Exp Med. 2004;199(3):369-379. (Pubitemid 38252049)
14. Gorska MM, Liang Q, Karim Z, Alam R. Uncoordinated 119 protein controls trafficking of Lck via the Rab11 endosome and is critical for immunological synapse formation. J Immunol. 2009;183(3):1675-1684.
15. Gorska MM, Goplen N, Liang Q, Alam R. Uncoordinated 119 preferentially induces Th2 differentiation and promotes the development of asthma. J Immunol. 2010;184(8):4488-4496.
16. Klippel JH. Primer on the Rheumatic Diseases. Atlanta, GA: Arthritis Foundation; 2001.
17. Cen O, Gorska MM, Stafford SJ, Sur S, Alam R. Identification of UNC119 as a novel activator of SRC-type tyrosine kinases. J Biol Chem. 2003;278(10):8837-8845. (Pubitemid 36800643)
18. Hasbold J, Gett AV, Rush JS, et al. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester. Immunol Cell Biol. 1999;77(6):516-522.
19. Walker UA, Warnatz K. Idiopathic CD4 lymphocytopenia. Curr Opin Rheumatol. 2006;18(4):389-395. (Pubitemid 44297285)
20. Hubert P, Bergeron F, Ferreira V, et al. Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. Int Immunol. 2000;12(4):449-457. (Pubitemid 30199350)
21. Moarefi I, LaFevre-Bernt M, Sicheri F, et al. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature. 1997;385(6617):650-653. (Pubitemid 27087580)
22. Gupta S, Weiss A, Kumar G, Wang S, Nel A. The T-cell antigen receptor utilizes Lck, Raf-1, and MEK-1 for activating mitogen-activated protein kinase. Evidence for the existence of a second protein kinase C-dependent pathway in an Lck-negative Jurkat cell mutant. J Biol Chem. 1994;269(25):17349-17357.
23. Goldman FD, Ballas ZK, Schutte BC, et al. Defective expression of p56lck in an infant with severe combined immunodeficiency. J Clin Invest. 1998;102(2):421-429. (Pubitemid 28335202)
24. Sawabe T, Horiuchi T, Nakamura M, et al. Defect of lck in a patient with common variable immunodeficiency. Int J Mol Med. 2001;7(6):609-614.
25. Zonios DI, Falloon J, Bennett JE, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 2008;112(2):287-294.
26. Rochman Y, Spolski R, Leonard WJ. New insights into the regulation of T cells by gamma(c) family cytokines. Nat Rev Immunol. 2009;9(7):480-490.
27. Wen T, Zhang L, Kung SK, Molina TJ, Miller RG, Mak TW. Allo-skin graft rejection, tumor rejection and natural killer activity in mice lacking p56lck. Eur J Immunol. 1995;25(11):3155-3159.
28. Sobacchi C, Marrella V, Rucci F, Vezzoni P, Villa A. RAG-dependent primary immunodeficiencies. Hum Mutat. 2006;27(12):1174-1184. (Pubitemid 44749719)
29. Niehues T, Perez-Becker R, Schuetz C. More than just SCID-the phenotypic range of combined immunodeficiencies associated with mutations in the recombinase activating genes (RAG) 1 and 2. Clin Immunol. 2010;135:183-192.
30. Zipfel PA, Zhang W, Quiroz M, Pendergast AM. Requirement for Abl kinases in T cell receptor signaling. Curr Biol. 2004;14(14):1222-1231. (Pubitemid 38991808)
31. Gu JJ, Zhang N, He YW, Koleske AJ, Pendergast AM. Defective T cell development and function in the absence of Abelson kinases. J Immunol. 2007;179(11):7334-7343.
32. Vepachedu R, Karim Z, Patel O, Goplen N, Alam R. Unc119 protects from Shigella infection by inhibiting the Abl family kinases. PLoS One. 2009;4(4):e5211.
33. Kobayashi A, Higashide T, Hamasaki D, et al. HRG4 (UNC119) mutation found in cone-rod dystrophy causes retinal degeneration in a transgenic model. Invest Ophthalmol Vis Sci. 2000;41(11):3268-3277.